Residual low hdv viremia is associated with hdv rna relapse after peg-ifna-based antiviral treatment of hepatitis d (delta): Results from the hidit-ii study

Bremer, BirgitAnastasiou, OlympiaHardtke, SvenjaCaruntu, Florin AlexandruCurescu, Manuela GabrielaYalcin, KendalAkarca, Ulus S.Idilman, RamazanZeuzem, StefanErhardt, AndreasLueth, StefanPapatheodoridis, GeorgeRadu, MonicaManns, Michael P.Cornberg, MarkusYurdaydın, CihanWedemeyer, Heiner2024-07-092024-07-092020-08-010168-8278https://hdl.handle.net/11452/43063eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineGastroenterology & hepatologyResidual low hdv viremia is associated with hdv rna relapse after peg-ifna-based antiviral treatment of hepatitis d (delta): Results from the hidit-ii studyMeeting Abstract000786587002509S868S86873Supplement 1